1e
19
1
49
2
2
18
1b
1d
18
45
63
1d
2 29
1d
25
Wei-Teng Yang, MD MPH AAHIVS FASAM FACP
78
63
Assistant Professor of Clinical Medicine (Infectious Diseases)
28
ae
3
5f
Director of Infectious Diseases Addiction Medicine Integration, Division of Infectious Diseases, Department of Medicine
c2
Physician Member, Multidisciplinary substance use associated infective endocarditis team at the Hospital of the University of Pennsylvania
76
Physician Member, Penn Center for Addiction Medicine and Policy
76
Per diem Infectious Diseases physician, Chester County Hospital
11
Department: Medicine
4
1
b
1d
46
Contact information
74
4
3
3
3
2
4
b
1f
74
3400 Spruce Street, Silverstein 3F, Suite E
Philadelphia, PA 19104
26
Philadelphia, PA 19104
35
a9
12
13
Education:
21 7 MD c
53 National Cheng Kung University College of Medicine, Taiwan, 2007.
21 8 MPH c
31 Johns Hopkins University, 2010.
c
3
3
3
3
8d
Permanent link21 7 MD c
53 National Cheng Kung University College of Medicine, Taiwan, 2007.
21 8 MPH c
31 Johns Hopkins University, 2010.
c
2 29
21
1e
1d
24
5e
26 29
27
Description of Clinical Expertise
37a Dr. Yang practices in infectious diseases and addiction medicine in the Hospital of the University of Pennsylvania and the Presbyterian Hospital. His clinical and academic interests are in the integration of infectious diseases and addiction care, and implementation of care models. He has extensive experiences working with marginalized populations and views addiction as the root cause of many infectious diseases. In his role of the Director of Infectious Diseases – Addiction Medicine Integration in the Division of Infectious Diseases, Dr. Yang sees inpatient consultations with the infectious diseases and addiction medicine teams and maintains an outpatient practice where he sees patients with concurrent infections and addiction. He is also involved in multidisciplinary work in infective endocarditis and xylazine associated wounds within the Penn health system.26 29
23
115 Yang, WT: Integrating Harm Reduction and Addiction Care in HIV Prevention among Persons Who Inject Drugs in the United States -- a Narrative Review. Ther Adv Infect Dis 1(12): 20499361251380642, Oct 2025.
129 Nacev, EC, Prewitt, KC, Yang, WT, Sokolski, E, Winer, JM, Rodulf, V, Englander, H, Liu, P: Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals. J Addict Med 1(5): 407, Aug 2025.
163 Yang, WT, Meisner, JA, Maguire, C, Dyer, KE, McFadden, R, Thakrar , AP, Dickinson, DT, Berg, D, Preston, A, David, MZ, Perrone, J, Talati, N, Degnan, KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12(6): ofaf299, Jun 2025.
1bc Ladines-Lim, JB,, Yang, WT, Tebas, P, O'Donnell, J, Koenig, H, Kreider, E, Dyer, K, Anwar, M, Rodriguez, E, Patel, S, Rodino, K, Glaser, L, Richterman, A.: Delayed diagnosis of disseminated Mycobacterium intracellulare subsp. chimaera infective endocarditis via cell-free metagenomic next-generation sequencing: a case report. ASM Case Reports 1(5): 2996-2684, May 2025.
1cb Stopka, TJ, Nance, RM, Mixson, LS, Spencer, H, Tsui, JI, Leahy,JM, Pho, MT, DeJace, J, Feinberg, J, Young, AM, Yang, WT, Baltes, A, Romo, E, Brown, RT, Nolte, K, Miller, WC, Zule, WA, Jenkins, WD, Delaney, JA, Friedmann, PD.: Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics? Trop Med Infect Dis 10(1): 17, Jan 2025.
174 Dyer, KE, Sabetan, S, Bourbeau, M, Yang, WT, Torgersen, J, Aitcheson, N: Integration of Comprehensive Infectious Disease Screening within an Inpatient Substance Detoxification Unit in Philadelphia: Capitalizing on Engagement Opportunities to Improve Patient Outcomes. AIDS, Munich, Germany Jul 2024.
15a Liu, AW, Yang, WT, Glick, SN, Kim, HN, Beieler, AM, Lan, KF, Dhanireddy, S, Tsui, JI.: Stimulant Co-use Is Associated With Patient-directed Discharges in Hospitalized Patients with Opioid Use and Injection Drug Use Related Infections. J Addict Med 17(6): 646-647, Sep 2023.
127 Yang WT, Dombrowski JC, Glick SN, Kim HN, Beieler AM, Lan KF, Dhanireddy S.: Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use. Open Forum Infect Dis 10(1): 5, Jan 2023.
21e Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A; NWCS 319 and ACTG PEARLS Study Team.: Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr 38(3): 1303-1309, Jun 2019.
2c
7
1d
1f
Selected Publications
16d Thakrar, AP; Lian, T; Carney, J; Yang, WT; Huo, S; Durkin, B; Oldridge, O; Lowenstein, M : Phenobarbital for benzodiazepine withdrawal among hospitalized patients with OUD. Association for Multidisciplinary Education and Research in Substance use and Addiction. Portland, OR, USA. Nov 2025.115 Yang, WT: Integrating Harm Reduction and Addiction Care in HIV Prevention among Persons Who Inject Drugs in the United States -- a Narrative Review. Ther Adv Infect Dis 1(12): 20499361251380642, Oct 2025.
129 Nacev, EC, Prewitt, KC, Yang, WT, Sokolski, E, Winer, JM, Rodulf, V, Englander, H, Liu, P: Feasibility of an Inpatient Split-Dose Rapid Methadone Induction Protocol for Pregnant Individuals. J Addict Med 1(5): 407, Aug 2025.
163 Yang, WT, Meisner, JA, Maguire, C, Dyer, KE, McFadden, R, Thakrar , AP, Dickinson, DT, Berg, D, Preston, A, David, MZ, Perrone, J, Talati, N, Degnan, KO.: Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds. Open Forum Infect Dis 12(6): ofaf299, Jun 2025.
1bc Ladines-Lim, JB,, Yang, WT, Tebas, P, O'Donnell, J, Koenig, H, Kreider, E, Dyer, K, Anwar, M, Rodriguez, E, Patel, S, Rodino, K, Glaser, L, Richterman, A.: Delayed diagnosis of disseminated Mycobacterium intracellulare subsp. chimaera infective endocarditis via cell-free metagenomic next-generation sequencing: a case report. ASM Case Reports 1(5): 2996-2684, May 2025.
1cb Stopka, TJ, Nance, RM, Mixson, LS, Spencer, H, Tsui, JI, Leahy,JM, Pho, MT, DeJace, J, Feinberg, J, Young, AM, Yang, WT, Baltes, A, Romo, E, Brown, RT, Nolte, K, Miller, WC, Zule, WA, Jenkins, WD, Delaney, JA, Friedmann, PD.: Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics? Trop Med Infect Dis 10(1): 17, Jan 2025.
174 Dyer, KE, Sabetan, S, Bourbeau, M, Yang, WT, Torgersen, J, Aitcheson, N: Integration of Comprehensive Infectious Disease Screening within an Inpatient Substance Detoxification Unit in Philadelphia: Capitalizing on Engagement Opportunities to Improve Patient Outcomes. AIDS, Munich, Germany Jul 2024.
15a Liu, AW, Yang, WT, Glick, SN, Kim, HN, Beieler, AM, Lan, KF, Dhanireddy, S, Tsui, JI.: Stimulant Co-use Is Associated With Patient-directed Discharges in Hospitalized Patients with Opioid Use and Injection Drug Use Related Infections. J Addict Med 17(6): 646-647, Sep 2023.
127 Yang WT, Dombrowski JC, Glick SN, Kim HN, Beieler AM, Lan KF, Dhanireddy S.: Partial-Oral Antibiotic Therapy for Bone and Joint Infections in People With Recent Injection Drug Use. Open Forum Infect Dis 10(1): 5, Jan 2023.
21e Shivakoti R, Ewald ER, Gupte N, Yang WT, Kanyama C, Cardoso SW, Santos B, Supparatpinyo K, Badal-Faesen S, Lama JR, Lalloo U, Zulu F, Pawar JS, Riviere C, Kumarasamy N, Hakim J, Pollard R, Detrick B, Balagopal A, Asmuth DM, Semba RD, Campbell TB, Golub J, Gupta A; NWCS 319 and ACTG PEARLS Study Team.: Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial. Clin Nutr 38(3): 1303-1309, Jun 2019.
2c